Alpha DNA Investment Management’s AMN Healthcare AMN Stock Holding History

Alpha DNA Investment Management’s Portfolio AMN Stock Details AMN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-12,135	Closed	-$1.01M	–	152
2023 Q1	$1.01M	Buy	+12,135	New	+$1.14M	0.3%	117
2022 Q3	–	Sell	-9,069	Closed	-$994K	–	151
2022 Q2	$994K	Buy	+9,069	New	+$898K	0.85%	57
2021 Q3	–	Sell	-15,516	Closed	-$1.5M	–	103
2021 Q2	$1.5M	Buy	15,516 +7,454	+92%	+$647K	1.03%	34
2021 Q1	$593K	Buy	8,062 +7,934	+6,198%	+$590K	0.68%	82
2020 Q4	$8K	Buy	+128	New	+$8.35K	0.01%	313

Other funds holding AMN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Holocene Advisors New York $44.4B AUM 57.89% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Alpha DNA Investment Management's AMN Position: Q2 2023 in Review

Alpha DNA Investment Management sold out of AMN Healthcare (AMN) in Q2 2023, closing a stake of 12,135 shares — an estimated $1.01M sold.

Alpha DNA Investment Management first reported a position in AMN in Q4 2020 and held it in 5 quarters. The position peaked at $1.5M in Q2 2021. 425 funds tracked by Wall St. Rank hold AMN as of Q2 2023.

Alpha DNA Investment Management reported no remaining AMN Healthcare position as of Q2 2023 after selling out during the quarter.
Alpha DNA Investment Management sold 12,135 AMN Healthcare shares in Q2 2023, an estimated $1.01M.
Alpha DNA Investment Management first reported a position in AMN Healthcare in Q4 2020 and held it in 5 quarters.
Alpha DNA Investment Management's AMN Healthcare position peaked at $1.5M in Q2 2021.
425 funds tracked by Wall St. Rank held AMN Healthcare as of Q2 2023.

Based on Alpha DNA Investment Management's 13F filing for Q2 2023, filed 31 Jul 2023.